Crestline Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRI
Weingarten Realty Investors
WRI
|
+$7.05M |
| 2 |
Kilroy Realty
KRC
|
+$6.77M |
| 3 |
Qualcomm
QCOM
|
+$6.53M |
| 4 |
NSA
National Storage Affiliates Trust
NSA
|
+$6.43M |
| 5 |
UDR
UDR
|
+$6.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$43.5M |
| 2 |
PG&E
PCG
|
+$10.2M |
| 3 |
American Homes 4 Rent
AMH
|
+$5.84M |
| 4 |
NXP Semiconductors
NXPI
|
+$5.81M |
| 5 |
Broadcom
AVGO
|
+$5.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.45% |
| 2 | Real Estate | 7.18% |
| 3 | Miscellaneous | 6.49% |
| 4 | Technology | 6.44% |
| 5 | Financials | 6.41% |
Similar funds
Crestline Management's Q3 2020 Portfolio in Review
As of Q3 2020, Crestline Management held 222 positions worth $678M, up 24% from $546M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Crestline Management deployed $51M of net new capital in Q3 2020, opening 62 new positions and adding to 19 existing holdings. Its largest new stake was Weingarten Realty Investors: 399,957 shares worth $6.78M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 61% a quarter earlier, followed by Real Estate and Miscellaneous.
On the sell side, the largest reduction was Denali Therapeutics, an estimated $43.5M trimmed.
- Crestline Management's largest Q3 2020 buy was Weingarten Realty Investors: 399,957 shares worth $6.78M.
- Crestline Management added most to Microchip Technology in Q3 2020, an estimated $3.98M increase.
- Crestline Management's biggest Q3 2020 reduction was Denali Therapeutics, cutting an estimated $43.5M.
- Crestline Management fully exited PG&E in Q3 2020, selling an estimated $10.2M.
- Crestline Management's ten largest holdings make up 74% of its $678M portfolio in Q3 2020.
- Crestline Management opened 62 new positions and closed 131 in Q3 2020.
- Crestline Management's portfolio value rose 24% quarter-over-quarter to $678M.
Based on Crestline Management's 13F filing for Q3 2020, filed 13 Nov 2020.